An Act To
Maine Legislature, Session 129, LD 1505
Committee Amendment CA_A_H513 (House)
Amends: 22 MRSA §2422, 22 MRSA §2423-A, 22 MRSA §2423-F, 22 MRSA §2425, 22 MRSA §2425-A, 22 MRSA §2426, 22 MRSA §2428, 22 MRSA §2429-A, 22 MRSA §2429-B, 22 MRSA §2429-C, 22 MRSA §2430, 22 MRSA §2430-G

COMMITTEE AMENDMENT "f)" to H.P. 1097, L.D. 1505, Bill, "An Act To 
Amend the Marijuana Laws To Correct Inconsistencies in Recently Enacted Laws" 
Amend the bill by striking out everything after the enacting clause and inserting the 
following: 
'Sec. 1. 22 MRSA §2422, sub-§§4-D to 4-1, as enacted by PL 2017, c. 447, §1 
and c. 452, §3, are repealed. 
Sec. 2. 22 MRSA §2422, sub-§§4-N to 4-S are enacted to read: 
4-N. 
Immature marijuana plant. 
"Immature marijuana plant" means a 
nonflowering marijuana plant that measures more than 24 inches from the base of the 
main plant stalk to the most distant point of the plant's leaf stems or branches. 
4-0. Inherently hazardous substance. "Inherently hazardous substance" means a 
liquid chemical; a compressed gas; carbon dioxide; or a commercial product that has -a 
flash point at or lower than 100 degrees Fahrenheit, including. but not limited to. butane, 
propane and diethyl ether. "Inherently hazardous substance" does not include any form of 
alcohol or ethanol. 
4-P. Long-term care facility. "Long-term care facility" means a hospice provider 
facility licensed under chapter 1681; a nursing facility licensed under chapter 405: an 
assisted living facility licensed under chapter 1663 or 1664; or a facility or program 
licensed under chapter 1663 that provides care for a qualifying patient in accordance with 
section 2423-A, subsection 1, paragraph F-1, subparagraph (2). 
4-0. Manufacture or manufacturing. "Manufacture" or "manufacturing" means 
the production, blending, infusing, compounding or other preparation of marijuana 
concentrate and marijuana products, including, but not limited to, marijuana extraction or 
preparation by means of chemical synthesis. 
4-R. Manufacturing facility. "Manufacturing facility" means a registered tier 1 or 
tier 2 manufacturing facility or a person authorized to engage in marijuana extraction 
under section 2423-F. 
COMMITTEE AMENDMENT 
COMMITTEEAMENDMENT"~"toH.P.1097,L.D.1505 
4-S. Marijuana concentrate. "Marijuana concentrate" means the resin extracted 
from any part of a marijuana plant and every compound, manufacture, salt, derivative, 
mixture or preparation from such resin, including, but not limited to, hashish. 
Sec. 3. 22 MRSA §2422, sub-§6, as amended by PL 2017, c. 452, §3, is further 
amended to read: 
6. Registered dispensary or dispensary. "Registered dispensary" or "dispensary" 
means an entity registered under section 2425-A that acquires, possesses, cultivates, 
manufactures, delivers, transfers, transports, sells, supplies or dispenses marijuana plants 
or harvested marijuana or related supplies and educational materials to qualifying patients 
and the caregivers of those patients. 
Sec. 4. 22 MRSA §2422, sub-§14-A, as amended by PL 2017, c. 447, §3 and c. 
452, §3, is repealed and the following enacted in its place: 
14-A. Sample. "Sample" means a marijuana plant or harvested marijuana that is 
provided for testing or research purposes to a marijuana testing facility. 
Sec. 5. 22 MRSA §2423-A, sub-§1, 1G, as amended by PL 2015, c. 475, §6, is 
further amended to read: 
G. Be in the presence or vicinity of the medical use of marijuana and assist any 
qualifying patient with using or administering harvested marijuana; 
Sec. 6. 22 MRSA §2423-A, sub-§1, ,ii, as amended by PL 2017, c. 447, §4 and 
c. 452, §4, is repealed and the following enacted in its place: 
H. 
Accept marijuana plants or harvested marijuana from a qualifying patient, 
caregiver or registered dispensary if no remuneration is provided to the patient, 
caregiver or dispensary; 
Sec. 7. 22 MRSA §2423-A, sub-§1, 1J, as enacted by PL 2017, c. 447, §6 and c. 
452, §4, is repealed and the following enacted in its place: 
J. 
Manufacture marijuana products and marijuana concentrate for medical use, 
except that a qualifying patient may not manufacture food, as defined in section 2152, 
subsection 4, unless the qualifying patient is licensed pursuant to section 2167 and 
except that a qualifying patient may not produce marijuana concentrate using 
inherently hazardous substances unless authorized pursuant to section 2423-F, 
subsection 3; 
Sec. 8. 22 MRSA §2423-A, sub-§1, ,iK, as enacted by PL 2017, c. 447, §6 and 
c. 452, §4, is repealed and the following enacted in its place: 
K. Provide harvested marijuana to a manufacturing facility and obtain marijuana 
products and marijuana concentrate from the manufacturing facility that are produced 
from the harvested marijuana the qualifying patient provided to the manufacturing 
facility; 
Sec. 9. 22 MRSA §2423-A, sub-§2, 1G, as repealed and replaced by PL 2017, c. 
447, §7 and amended by c. 452, §4, is repealed and the following enacted in its place: 
COMMITTEE AMENDMENT 
COMMITTEE AMENDMENT .. ;!,. to H.P. 1097, L.D. 1505 
G. 
Manufacture marijuana products and marijuana concentrate for medical use, 
except that a caregiver may not manufacture food, as defined in section 2152, 
subsection 4, unless the caregiver is licensed pursuant to section 2167 and except that 
a caregiver may not produce marijuana concentrate using inherently hazardous 
substances unless authorized pursuant to section 2423-F, subsection 3: 
Sec. 10. 22 MRSA §2423-A, sub-§2, ~' as amended by PL 2017, c. 447, §8 
and c. 452, §4, is repealed and the following enacted in its place: 
L. Provide samples to a marijuana testing facility for testing and research purposes: 
Sec. 11. 22 MRSA §2423-A, sub-§2, ~' as amended by PL 2017, c. 447, §8 
and c. 452, §4, is repealed and the following enacted in its place: 
M. 
Conduct marijuana testing at the request of anyone authorized to possess 
marijuana under this chapter for research and development purposes only: 
Sec. 12. 22 MRSA §2423-A, sub-§2, ~, as enacted by PL 2017, c. 447, §9 and 
c. 452, §4, is repealed and the following enacted in its place: 
N. Provide harvested marijuana to a manufacturing facility and obtain marijuana 
products and marijuana concentrate from the manufacturing facility that are produced 
from the harvested marijuana the caregiver provided to the manufacturing facility: 
Sec. 13. 22 MRSA §2423-A, sub-§10, as amended by PL 2017, c. 447, §10 and 
c. 452, §4, is repealed and the following enacted in its place: 
10. Marijuana testing facility. The following provisions apply to a marijuana 
testing facility. 
A. A marijuana testing facility that meets the requirements of this subsection and any 
rules adopted under paragraph D may receive and possess samples from qualifying 
patients, caregivers, dispensaries and manufacturing facilities to provide testing for 
the cannabinoid profile and potency of the samples and for contaminants in the 
samples, including but not limited to mold, mildew, heavy metals, plant regulators 
and illegal pesticides. For the purposes of this paragraph, "plant regulator" has the 
same meaning as in Title 7, section 604, subsection 26. 
B. An assistant of a marijuana testing facility may have access to cultivation areas 
pursuant to subsection 3, paragraphs A and B and section 2428, subsection 6, 
paragraph I. 
C. A marijuana testing facility shall: 
(1) Dispose of samples in a manner that prevents diversion of samples to persons 
not authorized to possess the samples tested by the facility: 
(2) House and store samples in the facility's possession or control during the 
process of testing, transport or analysis in a manner to prevent diversion, theft or 
loss: 
(3) Label samples being transported to and from the facility with the following 
statement: "For Testing Purposes Only": 
COMMITTEE AMENDMENT 
COMMITTEE AMENDMENT ,/1,, to H.P. 1097, L.D. 1505 
(4) Maintain testing results as part of the facility's business books and records; 
and 
(5) Operate in accordance with any rules adopted by the department. 
D. The department shall adopt routine technical rules as defined in Title 5, chapter 
375. subchapter 2-A governing marijuana testing facilities. including but not limited 
to: 
(1) Marijuana testing facility officer or director qualification requirements; 
(2) Required security for marijuana testing facilities; and 
(3) Requirements for the licensing, certifying or other approval of marijuana 
O 
testing facilities. 
The failure of the department to adopt rules under this paragraph does not prevent a 
marijuana testing facility from engaging in activities in compliance with this chapter. 
E. A marijuana testing facility shall obtain and must be able to produce. upon 
demand of the department or a municipal code enforcement officer, documentation of 
the facility's accreditation pursuant to standard ISO/IEC 17025 of the International 
Organization for Standardization by a 3rd-party accrediting body. The department 
may inspect a marijuana testing facility during regular business hours and hours of 
apparent activity for compliance with this chapter. 
Sec. 14. 22 MRSA §2423-A, sub-§11, as amended by PL 2017, c. 447, §11 and 
repealed by c. 452, §4, is repealed. 
Sec. 15. 22 MRSA §2423-A, sub-§12, as amended by PL 2017, c. 447, §12 and 
c. 452, §4, is repealed and the following enacted in its place: 
12. Interest. A caregiver or an officer or director of a registered dispensary. 
registered caregiver or manufacturing facility may not have a financial or other interest in 
a marijuana testing facility providing services associated with product labeling for that 
dispensary. caregiver or manufacturing facility. 
Sec. 16. 22 MRSA §2423-A, sub-§14, as enacted by PL 2017, c. 447, §14, is 
repealed. 
Sec. 17. 22 MRSA §2423-F, as enacted by PL 2017, c. 447, §15 and c. 452, §9, is 
repealed and the following enacted in its place: 
§2423-F. Marijuana manufacturing facilities 
A person may not manufacture marijuana products or marijuana concentrate or 
engage in marijuana extraction except as provided in this chapter. 
1. 
Tier 1 manufacturing facility. 
A tier 1 manufacturing facility registered 
pursuant to subsection 8 may engage in the activities authorized under subsection 4 in 
accordance with rules adopted pursuant to subsection 10 and may possess up to 40 
pounds of harvested marijuana. 
COMMITTEE AMENDMENT 
COMMITTEEAMENDMENTfi "toH.P.1097,L.D. 1505 
2. 
Tier 2 manufacturing facility. 
A tier 2 manufacturing facility registered 
pursuant to subsection 8 may engage in the activities authorized under subsection 4 in 
accordance with rules adopted pursuant to subsection 10 and may possess up to 200 
pounds of harvested marijuana. 
3. Authorization for extraction using inherently hazardous substances. This 
subsection governs the authority of a person to engage in marijuana extraction using 
inherently hazardous substances in accordance with subsection 5. 
A. A gualifying patient, caregiver. registered dispensary or manufacturing facility 
may engage in marijuana extraction using inherently hazardous substances if the 
person can produce. upon demand of the department: 
(1) Certification from a professional engineer licensed in this State of the safety 
of the eguipment used for marijuana extraction and the location of the eguipment 
and the professional engineer's approval of the standard operating procedures for 
the marijuana extraction: 
(2) Documentation from a professional engineer licensed in this State or a state 
or local official authorized to certify compliance that the eguipment used for 
marijuana extraction and the location of the equipment comply with state law and 
all applicable local and state building codes. electrical codes and fire codes. 
including the chapters of the most recent National Fire Protection Association 
Fire Code relating to marijuana extraction facilities; 
(3) Documentation from the manufacturer of the marijuana extraction system or 
a professional engineer licensed in this State showing that a professional grade. 
closed-loop extraction system that is capable of recovering the solvents used to 
produce marijuana concentrate is used by the person: and 
( 4) 
Evidence that the person has provided notice to the department of the 
person's intent to engage in marijuana extraction using inherently hazardous 
substances and the location where the marijuana extraction will occur prior to 
engaging in marijuana extraction using inherently hazardous substances. 
A person that intends to engage in marijuana extraction using inherently hazardous 
substances shall notify the department of that intention prior to engaging in marijuana 
extraction using inherently hazardous substances. The department may deny an 
application of a person authorized under this paragraph to register pursuant to rules 
adopted under subsection 10 if the person did not notify the department in accordance 
with this paragraph. 
B. A person that is not a gualifying patient. caregiver or dispensary and that meets 
the requirements of a person authorized under paragraph A. pays the fee reguired by 
section 2425-A. subsection 10 and meets the reguirements of rules adopted under 
subsection 10 is authorized to engage in marijuana extraction using inherently 
hazardous substances and may possess up to 40 pounds of harvested marijuana in 
accordance with subsection 5. 
4. Authorized conduct; manufacturing facilities. A registered manufacturing 
facility: 
COMMITTEE AMENDMENT 
COMMITTEE AMENDMENT .. ;4, to H.P. 1097, L.D. 1505 
A. May manufacture marijuana products and marijuana concentrate for medical use 
using any method that does not involve an inherently hazardous substance, except 
that a registered manufacturing facility may manufacture marijuana concentrate using 
inherently hazardous substances if authorized under subsection 3; 
B. 
May obtain harvested marijuana from a qualifying patient. a caregiver or a 
registered dispensary and may transfer marijuana products and marijuana concentrate 
to the person that provided the harvested marijuana used to manufacture the 
marijuana product or marijuana concentrate; 
C. May transfer samples to a marijuana testing facility for testing; 
D. 
May conduct testing of marijuana products or marijuana concentrate 
manufactured by the facility for research and development purposes; 
E. May receive reasonable compensation for manufacturing marijuana products or 
marijuana concentrate; 
F. Shall dispose of harvested marijuana used in the manufacturing process in a 
manner that prevents its diversion to persons not authorized to possess harvested 
marijuana possessed by the facility and in accordance with rules adopted by the 
department; and 
G. May hire any number of assistants to assist in performing the duties of the 
manufacturing facility. 
5. Authorized conduct; extraction using inherently hazardous substances. A 
person that is authorized to engage in marijuana extraction using inherently hazardous 
substances pursuant to subsection 3: 
A. May engage in marijuana extraction to produce marijuana concentrate for medical 
use; 
B. May obtain harvested marijuana from a qualifying patient. a caregiver or a 
dispensary and may transfer marijuana concentrate to the person that provided the 
harvested marijuana used to produce the marijuana concentrate; 
C. May transfer samples to a marijuana testing facility for testing; 
D. 
May conduct testing of marijuana concentrate produced by the person for 
research and development purposes; 
E. May receive reasonable compensation for producing marijuana concentrate; 
F. Shall dispose of harvested marijuana used in the extraction process in a manner 
that prevents its diversion to persons not authorized to possess harvested marijuana 
possessed by the person and in accordance with rules adopted by the department: and 
G. May hire any number of assistants to assist in performing the activities authorized 
under this subsection, except that a qualifying patient authorized under subsection 3 
may not hire an assistant. 
Notwithstanding the authorizations established in this subsection, a person that is 
authorized to engage in marijuana extraction using inherently hazardous substances 
pursuant to subsection 3 shall comply with any rules adopted pursuant to subsection 10. 
COMMITTEE AMENDMENT 
COMMITTEEAMENDMENT'A "toH.P.1097,L.D.1505 
6. Retail sale prohibited. A registered manufacturing facility or a person authorized 
to engage in marijuana extraction using inherently hazardous substances under subsection 
may not engage in retail sales of marijuana products or marijuana concentrate unless the 
person is authorized to engage in retail sales under this chapter. 
7. 
Food establishment license required to manufacture food products. 
A 
registered manufacturing facility or a person authorized to produce marijuana concentrate 
using inherently hazardous substances may not manufacture edible marijuana products or 
marijuana tinctures unless licensed pursuant to section 2167. 
8. Registration requirements. This subsection governs registration requirements of 
a manufacturing facility or a person authorized to engage in marijuana extraction using 
inherently hazardous substances under subsection 3 and the officer or director or assistant 
of the facility or person. 
A. 
In accordance with rules adopted under subsection 10. the department shall 
register and issue a registration certificate with a registry identification number to a 
manufacturing facility or a person authorized to engage in marijuana extraction 
within 30 days to the facility or person if the facility or person provides: 
(1) The annual fee required pursuant to section 2425-A. subsection 1 O; 
(2) The legal name of the facility or person and, if incorporated. evidence of 
incorporation and evidence that the corporation is in good standing with the 
Secretary of State; 
(3) The physical address of the facility or person or the physical address where 
an applicant who is an individual will engage in the activities authorized under 
this section. If the facility or person changes its physical location. or if a person 
registered under this subsection changes the location at which the person engages 
in activities authorized under this section, the facility or person shall notify the 
department of the new location; and 
(4) The name, address and date of birth of each officer or director of the facility 
or person. 
B. In accordance with rules adopted under subsection 10, the department shall issue 
registry identification cards to the officer or director or assistant of a registered 
manufacturing facility or person authorized to engage in marijuana extraction using 
inherently hazardous substances within 5 business days of approving an application 
or renewal under this subsection. A registry identification card is required to be 
issued to an officer or director or assistant of a registered manufacturing facility or 
person authorized to engage in marijuana extraction using inherently hazardous 
substances. A registry identification card expires one year after the date of issuance. 
A registry identification card issued under this paragraph must contain: 
(1) The name of the cardholder: 
(2) The date of issuance and expiration date of the regist1y identification card: 
and 
(3) A random identification number that is unique to the cardholder. 
COMMITTEE AMENDMENT 
COMMITTEEAMENDMENT'.,A "toH.P.1097,L.D.1505 
The department may not issue a registry identification card to an officer or director or 
assistant of a registered manufacturing facility or person authorized to engage in 
marijuana extraction using inherently hazardous substances who has been convicted 
of a disqualifying drug offense. The department shall conduct a criminal history 
record check of each person. officer or director or assistant subject to this subsection 
on an annual basis. 
If the department determines not to issue a registry identification card for a person. 
officer or director or assistant, the department shall notify the registered 
manufacturing facility or person authorized to engage in marijuana extraction using 
inherently hazardous substances in writing of the reason for denying the registry 
identification card. 
9. Packaging and labeling requirements. A manufacturing facility shall package 
and label its marijuana products and marijuana concentrate prior to transfer from the 
manufacturing facility in a form intended for use or consumption by a qualifying patient 
in tamper-evident packaging and with a label that includes the following information: 
A. The registry identification number of the manufacturing facility; 
B. Information that allows the provider of the marijuana to the manufacturing facility 
to confirm that the marijuana provided was used to manufacture the marijuana 
product or marijuana concentrate transferred back to that provider; 
C. Ingredients other than material derived from marijuana plants contained in the 
marijuana product or marijuana concentrate; and 
D. Any chemicals, solvents or other substances used to manufacture the marijuana 
product or marijuana concentrate. 
10. Rulemaking. The department shall adopt routine technical rules as defined in 
Title 5. chapter 375. subchapter 2-A governing manufacturing facilities, including but not 
limited to: 
A. Requirements for the registration of a manufacturing facility and an officer or 
director or assistant of a registered manufacturing facility; 
B. Requirements for engaging in marijuana extraction using inherently hazardous 
substances; 
C. Manufacturing facility officer or director qualification requirements; 
D. Required security for manufacturing facilities; 
E. 
Requirements of a disposal plan for harvested marijuana used in the 
manufacturing process: and 
F. Minimum record-keeping requirements, including an annual audit requirement. 
The failure of the department to adopt rules under this subsection does not prevent a 
7 
person authorized pursuant to subsection 3, paragraph A from engaging in conduct 
8 
authorized under this section. 
11. Multiple authorizations. A manufacturing facility or person registered pursuant 
to subsection 8 may also be a qualifying patient, a caregiver or a registered dispensary. A 
COMMITTEE AMENDMENT 
COMMITTEE AMENDMENT "A "to H.P. 1097, L.D. 1505 
manufacturing facility or person authorized to possess marijuana under this chapter may 
possess the amount allowed for that manufacturing facility or person in addition to the 
possession amount allowed under this section if the manufacturing facility or person is 
registered pursuant to this section. The marijuana possessed must be distinguishable with 
respect to the purposes for which it is authorized to be possessed. 
12. Record keeping. A registered manufacturing facility or person authorized to 
engage in marijuana extraction using inherently hazardous substances under subsection 3 
shall maintain records of all transactions in accordance with section 2430-G. 
13. Colocation of facilities. A manufacturing facility that is also licensed as an 
adult use marijuana products manufacturing facility under Title 28-B, chapter 1 may 
manufacture marijuana products and marijuana concentrate for adult use within the same 
facility in which the licensee also manufactures marijuana products or marijuana 
concentrate for medical use pursuant to this chapter. The following items or areas within 
the shared facility may be shared for both manufacturing pursuant to this chapter and 
pursuant to Title 28-B, chapter 1: 
A. 
Manufacturing-related and nonmanufacturing-related equipment, except that 
manufacturing-related equipment may not be simultaneously used for manufacturing 
pursuant to this chapter and pursuant to Title 28-B, chapter 1; 
B. Manufacturing-related and nonmanufacturing-related supplies or products not 
containing harvested marijuana and the storage areas for those supplies or products; 
and 
C. General office space, bathrooms, entryways and walkways. 
Sec. 18. 22 MRSA §2425, as amended by PL 2017, c. 447, §§16 to 18 and 
repealed by c. 452, §11, is repealed. 
Sec. 19. 22 MRSA §2425-A, sub-§3-A, 1,rE and F, as enacted by PL 2017, c. 
452, § 12, are amended to read: 
E. 
State and federal criminal history record information may be used by the 
department for the purpose of screening a ohild oare nrovider or ohild oare staff 
member person in accordance with this chapter. 
F. Information obtained pursuant to this subsection is confidential. The results of 
criminal history record checks received by the department are for official use only 
and may not be disseminated to any other person or entity. 
Sec. 20. 22 MRSA §2425-A, sub-§8, ~, as enacted by PL 2017, c. 452, §12, is 
amended to read: 
D. The physical address of the ce1tificate holder and, if the certificate holder is a 
dispensary, the physical address of one additional location, if any, where marijuana 
plants will be cultivated; and 
Sec. 21. 22 MRSA §2426, sub-§1, ,IE, as amended by PL 2017, c. 452, §13, is 
further amended to read: 
COMMITTEE AMENDMENT 
COMMITTEE AMENDMENT "A "to H.P. 1097, L.D. 1505 
E. Use or possess marijuana plants or harvested marijuana if that person is not a 
qualifying patient, caregiver, registered dispensary or other person authorized to use 
or possess marijuana under this chapter. 
Sec. 22. 22 MRSA §2428, sub-§1-A, ,ro, as amended by PL 2017, c. 447, §19 
and c. 452, § 16, is repealed and the following enacted in its place: 
D. Assist the qualifying patient with the medical use or administration of harvested 
marijuana: 
Sec. 23. 22 MRSA §2428, sub-§1-A, ,rE, as amended by PL 2017, c. 447, §20 
and c. 452, §16, is repealed and the following enacted in its place: 
E. Obtain harvested marijuana from a caregiver under section 2423-A, subsection 2, 
paragraph K; 
Sec. 24. 22 MRSA §2428, sub-§1-A, ,rF, as enacted by PL 2017, c. 447, §21 
and c. 452, § 16, is repealed and the following enacted in its place: 
F. Except as provided in section 2426: 
(1) Transfer marijuana plants and harvested marijuana to a qualifying patient and 
to a caregiver on behalf of a qualifying patient in a retail sale for reasonable 
compensation: 
(2) Transfer marijuana plants and harvested marijuana to a qualifying patient, 
caregiver or dispensary for no remuneration: 
(3) Acquire marijuana plants and harvested marijuana from another dispensary 
for no remuneration; 
(4) Transfer to and accept from a registered caregiver or another dispensary 
marijuana plants and harvested marijuana in a wholesale transaction in 
accordance with this paragraph. A dispensary may transfer in wholesale 
transactions for reasonable compensation or for no remuneration up to 30% of the 
mature marijuana plants grown by the dispensary over the course of a calendar 
year, including any marijuana products or marijuana concentrate manufactured 
from that 30% of the mature marijuana plants grown by the dispensary. A 
dispensary may transfer to or accept from registered caregivers and dispensaries 
in wholesale transactions an unlimited amount of immature marijuana plants and 
seedlings. 
A dispensary that acquires mature marijuana plants, marijuana 
products or marijuana concentrate in a wholesale transaction under this 
subparagraph may not resell the mature marijuana plants, marijuana products or 
marijuana concentrate except to a qualifying patient or to a caregiver or 
dispensary to assist a qualifying patient: 
(5) 
Transfer harvested marijuana to a manufacturing facility and accept 
marijuana products and marijuana concentrate from the manufacturing facility 
that are produced from the harvested marijuana the dispensary provided to the 
manufacturing facility; and 
(6) Provide samples to a marijuana testing facility for testing and research 
purposes; 
COMMITTEE AMENDMENT 
COMMITTEE AMENDMENT "A" to H.P. 1097, L.D. 1505 
Sec. 25. 22 MRSA §2428, sub-§1-A, ,rG, as enacted by PL 2017, c. 447, §21 
and c. 452, §16, is repealed and the following enacted in its place: 
G. 
Conduct marijuana testing at the request of anyone authorized to possess 
marijuana plants or harvested marijuana under this chapter for research and 
development purposes only; 
Sec. 26. 22 MRSA §2428, sub-§6, ,r:E, as amended by PL 2017, c. 452, §16, is 
further amended to read: 
E. A dispensary shall implement appropriate security measures to deter and prevent 
unauthorized entrance into areas containing marijuana plants and harvested marijuana 
and the theft of marijuana plants and harvested marijuana at the dispensary and the 
one permitted additional location at which the dispensary cultivates marijuana plants 
for medical use by qualifying patients. 
Sec. 27. 22 MRSA §2428, sub-§9, ,r:B, as amended by PL 2017, c. 452, §16, is 
further amended to read: 
B. A dispensary may not dispense, deliver or otherwise transfer marijuana plants or 
harvested marijuana except as provided in this chapter. 
Sec. 28. 22 MRSA §2429-A, sub-§4, as enacted by PL 2017, c. 452, §18, is 
amended to read: 
· 
4. 
Educational materials. 
A person that provides harvested marijuana to a 
qualifying patient must make educational materials about medieal the use of harvested 
marijuana available to the qualifying patient at the time of the transaction. The 
department shall develop the minimum content of the educational materials provided 
under this subsection and make that content available publicly. 
Sec. 29. 22 MRSA §2429-B, sub-§1, ,r:E, as enacted by PL 2017, c. 452, §18, is 
amended to read: 
E. 
Market to any person authorized to possess marijuana plants or harvested 
marijuana under this chapter and specifically to any adult use or recreational 
marijuana market within the same sign, advertisement or marketing material. 
Sec. 30. 22 MRSA §2429-C, sub-§5, as enacted by PL 2017, c. 452, §18, is 
amended to read: 
5. Addition to trademarked food or drink. May not involve the addition of 
harvested marijuana to a trademarked food or drink product, except when the 
trademarked product is used as a component of or ingredient in the edible marijuana 
product and the edible marijuana product is not advertised or described for sale as 
containing the trademarked product. 
Sec. 31. 22 MRSA §2430, sub-§5, as enacted by PL 2017, c. 452, §22, is 
7 
amended to read: 
5. 
Medical marijuana research grant program established. 
The medical 
marijuana research grant program, referred to in this subsection as "the program," is 
established within the department to provide grant money to support objective scientific 
research, including observational and clinical trials and existing research, on the efficacy 
COMMITTEE AMENDMENT 
COMMITTEE AMENDMENT "A" to H.P. 1097, L.D. 1505 
of harvested marijuana as part of medical treatment and the health effects of harvested 
marijuana used as part of medical treatment. The program must be funded from the fund. 
The department shall adopt rules necessary to implement the program, including, but not 
limited to, required qualifications of persons conducting the research; determining the 
scientific merit and objectivity of a research proposal; criteria for determining the amount 
of program funds distributed; criteria for determining the duration of the research; 
procedures for soliciting research participants, including outreach to patients, and for 
obtaining the informed consent of participants; and reporting requirements for the results 
of the research and evaluation of the research results. Rules adopted pursuant to this 
subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2-A. 
Sec. 32. 22 MRSA §2430-G, sub-§1, ,rB, as enacted by PL 2017, c. 452, §24, is 
amended to read: 
B. The department shall develop and implement a statewide electronic portal through 
which registered caregivers, registered dispensaries, marijuana testing facilities and 
manufacturing facilities may submit to the department the records required under 
paragraph A and in accordance with rules adopted by the department. A registered 
caregiver. registered dispensary. marijuana testing facility and manufacturing facility 
shall pay all costs and fees associated with the use of this electronic portal and all 
other fees associated with the keeping of records required in this section in 
accordance with rules adopted by the department. The department shall adopt rules 
regarding the process and content of records to be submitted, the frequency with 
which the records must be submitted. the costs and fees associated with using the 
electronic portal and any other requirements necessary to implement this paragraph.' 
Amend the bill by relettering or renumbering any nonconsecutive Part letter or 
section number to read consecutively. 
SUMMARY 
This amendment, which is the unanimous report of the committee, replaces the bill, 
which is a concept draft. It corrects technical conflicts and other errors or inconsistencies 
that resulted when both Public Law 2017, chapter 44 7 and Public Law 2017, chapter 452 
were enacted in the 128th Legislature. It also provides that a registered caregiver, 
registered dispensary, marijuana testing facility and manufacturing facility are required to 
pay all costs and fees associated with the use of the statewide electronic portal for record 
keeping. 
FISCAL NOTE REQUIRED 
(See attached) 
COMMITTEE AMENDMENT 
Approved: 05/29/19 feac. 
LD 1505 
LR 2429(02) 
An Act To Amend the Marijuana Laws To Correct Inconsistencies in Recently Enacted Laws 
Fiscal Note for Bill as Amended by Committee Amendment ,/J,,(_ //-_!;'/ ~ 
Committee: Health and Human Services 
Fiscal Note Required: Yes 
Fiscal Note 
Minor cost increase - Other Special Revenue Funds 
Fiscal Detail and Notes 
Any additional costs to the Department of Administrative and Financial Services from the provisions of this bill are 
expected to be minor and can be absorbed within existing budgeted resources. 
LR2429(02) - Fiscal Note - Page 1 of 1